Targeting ageing in COVID-19 patients to prevent respiratory failure

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $297,936.16
  • Funder

    UFM Denmark
  • Principal Investigator

    Associate Professor Morten Scheibye-Knudsen
  • Research Location

    Denmark
  • Lead Research Institution

    Center for Healthy Aging, Dpt. of Cellular and Molecular Medicine, University of Copenhagen
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)Older adults (65 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The mortality rate of 80-year- old COVID-19 patients is about 100 times greater than that of a 30-year-old patients. This project will treat older patients with a substance similar to vitamin B and Will investigate what factors make elderly people vulnerable to COVID-19. All in all, the project may lead to a possible treatment of COVID- 19 and an understanding of why elderly people are so particularly vulnerable to this virus.